Answers are grounded in this paper and cite their sources.
Demonstrates inhibitory activity of scortechinone D derivatives against EGFR tyrosine kinase, suggesting potential therapeutic use.
Three new scortechinone D derivatives ( 2 – 4 ) were effectively obtained through in situ halogenation of scortechinone D ( 1 ) using Oxone and sodium halide in a mixture of acetonitrile and water (5:1 ratio). All compounds were characterized using 1D and 2D NMR spectroscopy and high-resolution mass spectrometry. Single crystal-XRD was successfully performed on the compound 4 possessing iodo group at C-17. Among the four compounds ( 1 – 4 ) tested, compound 2 showed good inhibitory activity against EGFR tyrosine kinase with an inhibition value of 63.5% at 10 μM and modest toxicity against WI-38 normal cell line with 58.8% growth suppression at the same concentration. Despite the considerable toxicity of the active compound, this discovery offers a novel insight into the reactivity and bioactivity of scortechinone D analogs.
No takes yet. Share an insight, caveat, or question.
Danova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: